Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.788; its P/E ratio is -0.91; Tenaya Therapeutics is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -34.55M	$ -31.30M	$ -28.62M	$ -31.15M	$ -26.16M
EBITDA	$ -32.43M	$ -29.21M	$ -27.32M	$ -30.19M	$ -25.37M
Net Income Common Stockholders	$ -33.52M	$ -30.70M	$ -28.40M	$ -31.06M	$ -26.15M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 186.53M	$ 149.45M	$ 180.92M	$ 210.45M	$ 251.30M
Total Assets	$ 278.94M	$ 226.31M	$ 255.93M	$ 281.50M	$ 314.19M
Total Debt	$ 15.10M	$ 16.06M	$ 17.00M	$ 15.17M	$ 15.70M
Net Debt	$ -171.43M	$ -133.39M	$ -163.92M	$ -195.29M	$ -235.60M
Total Liabilities	$ 35.57M	$ 29.98M	$ 32.06M	$ 32.40M	$ 35.66M
Stockholders Equity	$ 243.38M	$ 196.33M	$ 223.87M	$ 249.10M	$ 278.53M
Cash Flow	-
Free Cash Flow	$ -23.48M	$ -31.62M	$ -32.61M	$ -37.35M	$ -28.90M
Operating Cash Flow	$ -22.68M	$ -27.56M	$ -25.43M	$ -28.76M	$ -16.35M
Investing Cash Flow	$ 5.97M	$ 31.03M	$ 30.21M	$ 16.43M	$ -62.58M
Financing Cash Flow	$ 77.49M	$ 6.00K	$ 260.00K	$ 15.00K	$ -21.00K

Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Income Statement >

Tenaya Therapeutics Debt to Assets

Balance Sheet >

Tenaya Therapeutics Cash Flow

Cash Flow >

Tenaya Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing